{"id":73310,"date":"2025-06-13T11:00:07","date_gmt":"2025-06-13T09:00:07","guid":{"rendered":"https:\/\/fournel-advisory.com\/?post_type=transaction&p=73310"},"modified":"2025-06-13T17:18:05","modified_gmt":"2025-06-13T15:18:05","slug":"ma-acquisition","status":"publish","type":"transaction","link":"https:\/\/fournel-advisory.com\/en\/transaction\/ma-acquisition\/","title":{"rendered":"M&A Acquisition"},"content":{"rendered":"

FOURNEL ADVISORY\u00a0<\/strong>advises ATHENA PHARMACEUTICALS on the acquisition of 100% of MEDIPHA SANT\u00c9\u2019s shares and the structuring of its financing<\/p>\n\n\n\n

Athena develops and manufactures high value-added medicines for both mature and emerging markets. The company offers an integrated platform covering the full value chain\u2014from R&D to commercialization\u2014through its two manufacturing sites in France and India (with a third site planned for 2026) and its R&D centers.<\/p>\n\n\n\n

This acquisition enables Athena Pharmaceuticals to strengthen its footprint in France and broaden its offering with complementary expertise, thereby consolidating its position as a leading integrated player in pharmaceutical services at the European level.<\/p>\n\n\n\n

Medipha Sant\u00e9 is a well-established pharmaceutical services company in France, specializing in marketing authorization holding, regulatory affairs, and pharmacovigilance<\/p>","protected":false},"excerpt":{"rendered":"

FOURNEL ADVISORY\u00a0accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition de 100% des titres MEDIPHA SANT\u00c9 et la mise en place de son financement Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&D \u00e0 la commercialisation, via ses deux sites industriels en France […]<\/p>","protected":false},"author":1,"featured_media":73311,"template":"","type_transaction":[93],"class_list":["post-73310","transaction","type-transaction","status-publish","has-post-thumbnail","hentry","type_transaction-acquisition"],"acf":[],"yoast_head":"\nM&A Acquisition - FOURNEL ADVISORY<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fournel-advisory.com\/en\/transaction\/ma-acquisition\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M&A Acquisition - FOURNEL ADVISORY\" \/>\n<meta property=\"og:description\" content=\"FOURNEL ADVISORY\u00a0accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition de 100% des titres MEDIPHA SANT\u00c9 et la mise en place de son financement Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&D \u00e0 la commercialisation, via ses deux sites industriels en France […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fournel-advisory.com\/en\/transaction\/ma-acquisition\/\" \/>\n<meta property=\"og:site_name\" content=\"FOURNEL ADVISORY\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-13T15:18:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png\" \/>\n\t<meta property=\"og:image:width\" content=\"694\" \/>\n\t<meta property=\"og:image:height\" content=\"694\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/\",\"url\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/\",\"name\":\"M&A Acquisition - FOURNEL ADVISORY\",\"isPartOf\":{\"@id\":\"https:\/\/fournel-advisory.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png\",\"datePublished\":\"2025-06-13T09:00:07+00:00\",\"dateModified\":\"2025-06-13T15:18:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#primaryimage\",\"url\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png\",\"contentUrl\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png\",\"width\":694,\"height\":694},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/fournel-advisory.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions\",\"item\":\"https:\/\/fournel-advisory.com\/transactions\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"M&A Acquisition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fournel-advisory.com\/#website\",\"url\":\"https:\/\/fournel-advisory.com\/\",\"name\":\"FOURNEL ADVISORY\",\"description\":\"Une soci\u00e9t\u00e9 de conseil sp\u00e9cialis\u00e9e en fusions-acquisitions, lev\u00e9e de fonds et situations sp\u00e9ciales.\",\"publisher\":{\"@id\":\"https:\/\/fournel-advisory.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fournel-advisory.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fournel-advisory.com\/#organization\",\"name\":\"FOURNEL ADVISORY\",\"url\":\"https:\/\/fournel-advisory.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png\",\"contentUrl\":\"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png\",\"width\":2363,\"height\":1323,\"caption\":\"FOURNEL ADVISORY\"},\"image\":{\"@id\":\"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M&A Acquisition - FOURNEL ADVISORY","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fournel-advisory.com\/en\/transaction\/ma-acquisition\/","og_locale":"en_GB","og_type":"article","og_title":"M&A Acquisition - FOURNEL ADVISORY","og_description":"FOURNEL ADVISORY\u00a0accompagne ATHENA PHARMACEUTIQUES dans l\u2019acquisition de 100% des titres MEDIPHA SANT\u00c9 et la mise en place de son financement Athena d\u00e9veloppe et fabrique des m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e destin\u00e9s aux march\u00e9s matures et \u00e9mergents. L\u2019entreprise propose une plateforme int\u00e9gr\u00e9e, allant de la R&D \u00e0 la commercialisation, via ses deux sites industriels en France […]","og_url":"https:\/\/fournel-advisory.com\/en\/transaction\/ma-acquisition\/","og_site_name":"FOURNEL ADVISORY","article_modified_time":"2025-06-13T15:18:05+00:00","og_image":[{"width":694,"height":694,"url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/","url":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/","name":"M&A Acquisition - FOURNEL ADVISORY","isPartOf":{"@id":"https:\/\/fournel-advisory.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#primaryimage"},"image":{"@id":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#primaryimage"},"thumbnailUrl":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png","datePublished":"2025-06-13T09:00:07+00:00","dateModified":"2025-06-13T15:18:05+00:00","breadcrumb":{"@id":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#primaryimage","url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png","contentUrl":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2025\/06\/Athena-x-Medipha-FR.png","width":694,"height":694},{"@type":"BreadcrumbList","@id":"https:\/\/fournel-advisory.com\/transaction\/ma-acquisition\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/fournel-advisory.com\/"},{"@type":"ListItem","position":2,"name":"Transactions","item":"https:\/\/fournel-advisory.com\/transactions\/"},{"@type":"ListItem","position":3,"name":"M&A Acquisition"}]},{"@type":"WebSite","@id":"https:\/\/fournel-advisory.com\/#website","url":"https:\/\/fournel-advisory.com\/","name":"FOURNEL ADVISORY","description":"Une soci\u00e9t\u00e9 de conseil sp\u00e9cialis\u00e9e en fusions-acquisitions, lev\u00e9e de fonds et situations sp\u00e9ciales.","publisher":{"@id":"https:\/\/fournel-advisory.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fournel-advisory.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/fournel-advisory.com\/#organization","name":"FOURNEL ADVISORY","url":"https:\/\/fournel-advisory.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/","url":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png","contentUrl":"https:\/\/fournel-advisory.com\/wp-content\/uploads\/2024\/08\/Logo-FA-Blanc.png","width":2363,"height":1323,"caption":"FOURNEL ADVISORY"},"image":{"@id":"https:\/\/fournel-advisory.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/transaction\/73310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/transaction"}],"about":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/types\/transaction"}],"author":[{"embeddable":true,"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/media\/73311"}],"wp:attachment":[{"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/media?parent=73310"}],"wp:term":[{"taxonomy":"type_transaction","embeddable":true,"href":"https:\/\/fournel-advisory.com\/en\/wp-json\/wp\/v2\/type_transaction?post=73310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}